Nautilus Biotechnology, Inc.

NAUTSEC EDGAR

Laboratory Analytical InstrumentsCIK: 1808805

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Research and Development Expense	$50.5M	$47.3M	$37.7M	$29.4M	$12.4M
Operating Expenses	$81.5M	$76.2M	$63.6M	$50.5M	$15.7M
Operating Income (Loss)	—	—	—	—	—
Nonoperating Income (Expense)	$10.7M	$12.5M	$5.7M	$183.0K	$125.0K
Income Tax Expense (Benefit)	$0.00	$0.00	$0.00	$0.00	$0.00
Net Income (Loss) Attributable to Parent	-$70.8M	-$63.7M	-$57.9M	-$50.3M	-$15.6M
Earnings Per Share, Basic	-$0.56	-$0.51	-$0.46	-$0.60	-$0.54
Earnings Per Share, Diluted	-$0.56	-$0.51	-$0.46	-$0.60	-$0.54

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$242.7M	$305.6M	$350.1M	$398.4M	$85.0M
Assets, Current	$132.8M	$176.8M	$187.2M	$349.2M	$77.7M
Cash and Cash Equivalents, at Carrying Value	$27.6M	$19.4M	$114.5M	$185.6M	$36.6M
Liabilities	$34.0M	$40.2M	$35.1M	$34.9M	$6.3M
Liabilities, Current	$7.6M	$9.1M	$6.8M	$5.8M	$3.0M
Accounts Payable, Current	$987.0K	$1.6M	$1.3M	$1.7M	$470.0K
Stockholders' Equity Attributable to Parent	$265.4M	$314.9M	$363.6M	-$29.7M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$59.1M	-$51.7M	-$45.8M	-$39.2M	-$14.0M
Net Cash Provided by (Used in) Investing Activities	$66.3M	-$43.7M	-$25.7M	-$139.0M	-$25.3M
Net Cash Provided by (Used in) Financing Activities	$1.1M	$368.0K	$562.0K	$327.4M	$75.9M
Payments to Acquire Property, Plant, and Equipment	$2.1M	$2.4M	$2.3M	$2.3M	$921.0K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)